Hikma Pharmaceuticals PLC/ GB00B0LCW083 /
2024-04-18 7:57:19 AM | Chg. 0.0000 | Volume | Bid6:07:15 PM | Ask6:07:15 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
21.2000EUR | 0.00% | - Turnover: - |
21.0000Bid Size: 240 | 21.2000Ask Size: 240 | 4.64 bill.EUR | - | - |
GlobeNewswire
2021-02-25
Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
GlobeNewswire
2021-01-26
Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care Insu...
GlobeNewswire
2020-01-09
Arecor and Hikma Announce Exclusive Agreement to Develop and Commercialise Ready-To-Use Medicine Usi...
GlobeNewswire
2019-06-03
Gout Therapeutic Market is projected to reach US$ 3820 Million by 2027- TMR